Información del producto
DS21360717 is a potent, orally active, small-molecule inhibitor of the kinase domain of human erythropoietin receptor (EPOR). DS21360717 has been shown to inhibit cancer cell growth in vitro and in vivo. It also inhibits the proliferation of leukemic cells. In addition, DS21360717 has been shown to be potent inducers of hematopoietic cells and breast cells. Inhibition of EPOR kinase activity has been observed using molecular modeling and structural analysis. These findings suggest that DS21360717 may have therapeutic potential for inflammatory diseases, such as rheumatoid arthritis, psoriasis, ulcerative colitis, Crohn's disease, and asthma.
Propiedades químicas
Consulta técnica sobre: 3D-ESD65443 DS21360717
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
